THE ENRICO FERMI YEAR

A TRIBUTE TO THE "ITALIAN NAVIGATOR" FATHER OF THE WEAK FORCES

GALILEO GALILEI FOUNDATION
WORLD FEDERATION OF SCIENTISTS
ETTORE MAJORANA CENTRE FOR SCIENTIFIC CULTURE

GALILEO GALILEI CELEBRATIONS
Four Hundred Years Since the Birth of MODERN SCIENCE

INTERNATIONAL SCHOOL OF PHARMACOLOGY

63rd Course:

ANGIOGENESIS AND SIGNAL TRANSDUCTION IN ANTI-CANCER DRUG DEVELOPMENT

ERICE-SICILY: 25-30 APRIL 2001

Sponsored by the:

• Italian Ministry of University, Scientific Research and Technology
• Sicilian Regional Government

PROGRAMME AND LECTURERS

Angiogenesis
Signal transduction
Anti-angiogenic therapy
Vascular targeting
Chemotherapy/Immunotherapy
Tyrosine kinase antagonists
Apoptosis
Growth factors
Molecular drug design
• B. Bonavida, University of California, Los Angeles, CA, USA
• M. Botta, University of Siena, I
• D.J. Chaplin, Oxigene, Boston, MA, USA
• J. Cherrington, Sugen, San Francisco, CA, USA
• G. Christofori, Research Institute of Molecular Pathology, Vienna, A
• C. Dive, University of Manchester, UK
• N. Ferrara, Genentech, San Francisco, CA, USA
• R. Kerbel, University of Toronto, Toronto, CDN
• A. Kikuchi, Hiroshima University School of Medicine, J
• E. Kohn, National Cancer Institute, Bethesda, MD, USA
• D. Mochly-Rosen, Stanford University, CA, USA
• D. Neri, Institut für Pharmazeutische Wissenschaften, Zurich, CH
• R. Pasqualini, University of Texas, Houston, TX, USA
• J. Pouyssegur, CNRS-INSERM-UNSA, Nice, F
• C. Riccardi, University of Perugia, I
• E. Sausville, National Cancer Institute, Bethesda, MD, USA
• D. Simoni, University of Ferrara, I
• P. Thorpe, University of Texas, Dallas, TX, USA
• J. Wood, Novartis AG, Basel, CH

PURPOSE OF THE COURSE

The intracellular characterization of the signalling cascades activated during the interactions between tumour and stromal cells have the potential to identify useful targets for the development of new antitumour agents. Multiple targeting strategies directed at the tumour and activated endothelial cells could work in concert, synergise and result in tumour regression. The objective of the Course is to discuss in depth the recent advances achieved in the molecular and cellular mechanisms of angiogenesis and signal transduction for the development of new strategies in the treatment of cancer. The latest data on therapeutic agents under clinical development will be presented and critically discussed. This Course provides a unique opportunity for the participants to network, challenge current dogmas and exchange ideas in this rapidly moving field. Participants will benefit from the Course through their exposure to the latest developments and breakthroughs presented by international experts, their active participation in discussion workshops, and one-on-one interaction with the experts. Further, participants will present their research experience by posters.

The format of the Course will optimize the time and effort devoted by the invited experts and by the participating students and faculty.

APPLICATIONS

Persons wishing to attend the Workshop should apply in writing to:

• Professor Natale D'ALESSANDRO
  Dipartimento di Scienze Farmacologiche
  Policlinico "P. Giaccone"
  Via del Vespro, 129 - 90127 PALERMO, Italy
  Tel: ++39.091.6553258 Fax: ++39.091.6553249
  E-mail: dalessan@unipa.it

   

specifying:

i) Full name, address, age and nationality;
ii) Academic qualifications and number of publications;
iii) List of publications;
iv) Present position and place of work.

 

Closing date for application: February 28, 2001

 

• PLEASE NOTE
  Participants must arrive in Erice on April 25, 2001, not later than 5 p.m.